Screening method and application of aptamer for detecting acute promyelocyte leukemia
A technology for promyelocytic and leukemia, which is applied in biochemical equipment and methods, measuring devices, determination/examination of microorganisms, etc., can solve the problems that the specificity and accuracy of leukemia diagnosis needs to be further improved.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] 1. Synthesis of random single-stranded DNA library and primers
[0057] Random ssDNA library: 5'-ATC CAG AGT GAC GCA GCA-40nt-TGG ACA CGG TGG CTT
[0058] AGT-3'
[0059] Upstream fluorescein-labeled primer: 5'-FITC-ATC CAG AGT GAC GCA GCA-3'
[0060] Downstream biotinylated primer: 5'-BIO-ACT AAG CCA CCG TGT CCA-3'
[0061] Upstream primer: 5'-ATC CAG AGT GAC GCA GCA-3'
[0062] Downstream primer: 5'-ACT AAG CCA CCG TGT CCA-3'
[0063] 2. Cell-SELEX screening process
[0064] Cell-SELEX screening to obtain nucleic acid aptamers that specifically recognize acute promyelocytic leukemia
[0065] 2.1 Dissolve 1 μl of the 10 μM random ssDNA library above in 350 μl binding buffer, place in a constant temperature water bath at 95°C for 5 minutes, and then place it on an ice box immediately for use.
[0066] 2.2 Add 10% newborn bovine serum to the 1640 culture medium to cultivate acute promyelocytic leukemia HL-60 cells. When the number of cells reaches 5×10 6 / ml was t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com